bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate
Strong commercial adoption of lung cancer diagnostic test fuels investor enthusiasm Shares of bioAffinity Technologies (BIAF) experienced a dramatic rally, ...
Strong commercial adoption of lung cancer diagnostic test fuels investor enthusiasm Shares of bioAffinity Technologies (BIAF) experienced a dramatic rally, ...
Strategic partnerships, expanding capacity, and Nvidia backing highlight growing momentum in the neocloud sector Investor confidence is increasing in AI ...
Performance and Premium models arrive first, while the most affordable R2 won’t reach buyers until 2027 Electric vehicle maker Rivian ...
Billionaire restaurateur and casino operator reportedly pursuing $7 billion deal after surpassing rival bid Billionaire entrepreneur Tilman Fertitta is reportedly ...
Company advances C. difficile treatment program toward Phase 3 international studies Acurx Pharmaceuticals (ACXP) saw its shares move higher after ...
Cloud performance and raised 2027 revenue target fuel investor optimism despite heavy AI infrastructure spending Oracle Corporation (ORCL) saw its ...
Tech giant targets up to $42 billion across U.S. and European markets to finance data centers and advanced computing infrastructure ...
Collaboration targets international oil, gas, and petrochemical trading opportunities AGAPE ATP Corporation (ATPC), through its subsidiary ATPC Green Energy Sdn. ...
Institutional demand, ETF flows, and expanding blockchain adoption could fuel the next major rally Ethereum (ETH) is increasingly being viewed ...
Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny Shares of Hims & Hers Health (HIMS) ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?